AP30663 is a KCa2 channel inhibitor that can be used for the study of atrial fibrillation.
References:
[1]. Holst A G, Tomcsányi J, Vestbjerg B, et al. Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial[J]. Nature Medicine, 2023: 1-6.
















